Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Nuclear Medicine and Molecular Imaging: Radionuclide Therapy and Dosimetry

Radionuclide Therapy and Dosimetry

Therapy and Dosimetry Case File

Cases may be found on the Icon website: under development

Beylergil V., et al. (2013) A Historical Perspective on the Use of Radionuclides for Therapy. In: Baum R. (eds) Therapeutic Nuclear Medicine. Medical Radiology. Springer, Berlin, Heidelberg.

Theranostics and Dosimetry (General)

Gomes Marin JF, et al. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology. Radiographics. 2020 Oct;40(6):1715-1740.

Iodine-131 Thyroid Cancer

Haugen BR, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.

Francis GL, et al; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59.

Iodine-131 Hyperthyroidism

Ross DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-1421.

Silberstein EB, et al. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med. 2012 Oct;53(10):1633-51.

Iodine-131 iobenguane (Azedra)

Lutetium-177 dotatate (Lutathera)

Burkett BJ, et al. How We Do It: A Multidisciplinary Approach to 177Lu DOTATATE Peptide Receptor Radionuclide Therapy. Radiology. 2021 Feb;298(2):261-274.

Bellizzi AM. Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am. 2020 Apr;29(2):185-208.

Hope TA, Bergsland EK, Bozkurt MF, et al. Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors. J Nucl Med. 2018;59(1):66-74. doi:10.2967/jnumed.117.202275 

Pencharz D, Gnanasegaran G, Navalkissoor S. Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy. Br J Radiol. 2018;91(1091):20180108. doi:10.1259/bjr.20180108

Radium-223 chloride (Xofigo)

Yttrium-90 microspheres (SirTex and Theraspheres)

Lee EJ, Chung HW, Jo JH, So Y. Radioembolization for the Treatment of Primary and Metastatic Liver Cancers. Nucl Med Mol Imaging. 2019 Dec;53(6):367-373. doi: 10.1007/s13139-019-00615-9.

Other Links